Additionally, NfL levels start to increase in blood more than 15 years before the first clinical manifestation of AD, as demonstrated by longitudinal studies on AD mutation carriers [237], possibly representing a useful marker to detect AD patients with prodromal psychopathological manifestations. Here, NEFL is linked to Alzheimer disease.